Jenna Kelsch
Nurse Practitioner · Minot, NDNPI 1528442803
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Medtronic at 47.2% of the total. Reporting peaked in 2024 at $4,005 and has fallen 79.0% since, to $842 in 2025. Among nurse practitioner clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $47.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Edwards Lifesciences$3K
- E.r. Squibb & Sons, L.L.C.$291
- Actelion Pharmaceuticals US, Inc.$186
- Boston Scientific$112
- Novartis$97
- plus $818 from 24 others
What the payments were for
- Travel & lodging$4,75951%
- Food & beverage$4,39948%
- Education$991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 86 | $4,372 |
| Edwards Lifesciences | 30 | $3,381 |
| E.r. Squibb & Sons, L.L.C. | 19 | $291 |
| Actelion Pharmaceuticals US, Inc. | 4 | $186 |
| Boston Scientific | 6 | $112 |
| Novartis | 7 | $97 |
| Amgen | 5 | $85 |
| W. L. Gore & Associates, Inc. | 4 | $66 |
| Abbott | 3 | $64 |
| United Therapeutics Corporation | 3 | $61 |
| Stryker | 2 | $52 |
| Lexicon Pharmaceuticals, Inc. | 3 | $52 |
| AstraZeneca | 1 | $45 |
| Angiodynamics, Inc. | 1 | $39 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Lemaitre Vascular, Inc. | 1 | $33 |
| Johnson & Johnson | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| Pfizer | 1 | $28 |
| Inari Medical, Inc. | 1 | $24 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Teleflex LLC | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Abiomed | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Cardiovascular Systems Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,258 in reported general payments places this provider in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 63 | $52,304 |
| JardianceEmpagliflozin | 32 | $30,448 |
| BrilintaTicagrelor | 59 | $26,439 |
| XareltoRivaroxaban | 32 | $25,623 |
| ClopidogrelClopidogrel Bisulfate | 401 | $5,736 |
| Metoprolol Succinate | 179 | $3,334 |
| Bumetanide | 23 | $1,789 |
| Rosuvastatin Calcium | 111 | $1,287 |
| Amiodarone Hcl | 35 | $1,238 |
| Atorvastatin Calcium | 63 | $923 |
| Prasugrel Hcl | 26 | $806 |
| Spironolactone | 86 | $674 |
| Pantoprazole Sodium | 45 | $622 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 23 | $595 |
| Potassium Chloride | 18 | $565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $28 | $52,30463 claims |
| Boehringer IngelheimJardiance | $15 | $30,44832 claims |
| AstraZenecaBrilinta | $45 | $26,43959 claims |
| Johnson & JohnsonXarelto | $30 | $25,62332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Minot
- Jaclin SeebergMinot$4K
- Wendy HaalandMinot$3K
- Leah BrewsterMinot$3K
- Jennifer NaporaMinot$2K
- Janet MaxsonMinot$1K
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- McKinzie NussBismarck$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.